Daphne Day
Monash Medical Centre · 100 works · 2,358 citations · h-index 16
Top works
- Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
- Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma
- Immune Checkpoint Inhibitor Therapy in Oncology
- Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors
- Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities
- Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials
- Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy
- Approaches to modernize the combination drug development paradigm
- Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature
- Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial
- Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
- COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study
- Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
- Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acid
- Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil‐to‐lymphocyte ratio in patients with metastatic renal cell carcinoma
- From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely
- Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
- Patterns of care for metastatic renal cell carcinoma in A ustralia
- Preliminary results for the advanced salivary gland carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab.
- Hypopharyngeal Cancer: Looking Back, Moving Forward